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Abstract Atrial septal defect (ASD) constitutes 30–40%
of all congenital heart diseases in adults. The most com-
mon complications in the treatment of ASD are
embolization of the device and thrombosis formation. In
this research, an occluding patch was developed for ASD
treatment using a well-known textile technology called
electrospinning. For the first time, a cardiovascular
occluding patch was fabricated using medical grade poly-
urethane (PU) loaded with bioactive agents namely chi-
tosan nanoparticles (Cn) and collagen (Co) which is then
coated with heparin (Hp). Fourier transform infrared
spectrum showed characteristic vibrations of several active
constituents and changes in the absorbance due to the
inclusion of active ingredients in the patch. The contact
angle analysis demonstrated no significant decrease in
contact angle compared to the control and the composite
patches. The structure of the electrospun nanocomposite
(PUCnCoHp) was examined through scanning electron
microscopy. A decrease in nanofiber diameter between
control PU and PUCnCoHp nanocomposite was observed.
Water uptake was found to be decreased for the PUCn-
CoHp nanocomposite against the control. The hemocom-
patibility properties of the PUCnCoHp ASD occluding
patch was inferred through in vitro hemocompatibility tests
like activated partial thromboplastin time (APTT), pro-
thrombin time (PT) and hemolysis assay. It was found that
the PT and APTT time was significantly prolonged for the
fabricated PUCnCoHp ASD occluding patch compared to
the control. Likewise, the hemolysis percentage was also
decreased for the PUCnCoHp ASD patch against the
control. In conclusion, the developed PUCnCoHp patch
demonstrates potential properties to be used for ASD
occlusion.
Keywords Atrial septal defect  Blood compatibility 
Textile technology  Electrospinning  Cardiac patch 
Nanofibers
Introduction
Postoperative erosion of the aortic or atrial wall is a
dreadful complication of percutaneous septal defect closure
using an atrial septal occluder (ASO). Erosion event is the
chief concern since it occurs in a vulnerable pediatric
population. It decreases the ability to predict those patients
who may be at high risk and may lead to an urgent life
threatening event (Fornell 2013). These events occur in
almost 1–3 of every 1000 patients implanted with the ASO.
According to latest survey, a massive 234,103 ASO devices
were sold worldwide. The risks allied with device removal
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surgery may be equal to or higher than the risk of erosion
(Fornell 2013). A review was performed for determining
the occurrence of erosion events in the ASO. It was found
that there are 25 pertinent articles ascertaining the cases of
cardiac erosion coupled with the ASO and 21 independent
surgically confirmed cases (case reports), 1 suspected event
and 79 distinct events reported in case series and review
articles (Crawford et al. 2012). Stroke due to late ASO
thrombosis was reported in a recent study. Further, the
occurrence of recurrent neurologic events in these same
studies has ranged between 0 and 2.6% (Korabathina et al.
2012). Moreover, allergy to nickel occurs in up to 15% of
the population where adverse events observed in 37
patients with ASO (Wertman et al. 2006).
Fully absorbable ASO occlude may resolve the concerns
relating to permanent devices by eliminating utilization of
non-degradable materials specifically the metal. A
biodegradable occluder not only closes the hole, but also
confers a temporary scaffold for the in-growth of host
tissue to cover the device and the defect underneath.
Ultimately, the device may degrade into nontoxic ingre-
dients and then be fully absorbed thereby leaving the
‘‘native’’ tissue behind. This notion can minimize the
potential for future complications triggered by the presence
of a foreign body (Liu et al. 2011). Polyurethane (PU) is a
commonly available polymer and it mainly contains ure-
thane linkage. The urethane linkage is formed by the
reaction between isocyanates and aldols. The PU has
higher elasticity, toughness, resistance to oxidation, tear
and humidity. Further, the cost involved in production of
polyether derivatives is low which can reduce the cost
associated with metallic frames made from nitinol which is
a shape memory alloy (SMA). The PU is a shape memory
polymer capable of 100% shape regain even when it is
stretched above its glass transition temperature. Farzaneh
et al. deformed the polyurethane in the glass transition zone
or at a higher temperature and found that the polymer
completely regains its shape after mechanical deformation
making polyurethane an excellent substitute for the nitinol
(Farzaneh et al. 2013). The presence of hard domains plays
a vital role in shaping the inelastic properties of PU by
increasing the crosslinking of the polymer chains. With the
improved volume fraction of domains dominated by hard
segments, these domains are better cross-linked and inter-
connected thereby making them a promising polymer for
occluder. The commercial elastomeric polyurethane (Te-
coflex EG-80A) which is used in this research was a
medical grade PU and already used in the clinical appli-
cation of vascular grafts because of its elastomeric property
and good compatibility. In addition, its slow degradation
rate is inferred to match with the synthesis of ECM com-
ponents and cardiac tissue regeneration process for the
closure of ASD (Detta et al. 2010).
There are several studies indicating that the chitosan
nanoparticles (Cn) improve the mechanical strength of the
matrix in which they embedded. For instance, the Cn were
found to improve the mechanical property of hydrox-
ypropyl methylcellulose (HPMC) films suggesting that Cn
are promising fillers to bolster the strength of the matrix
material (Moura et al. 2008, 2009). Likewise, in another
study Cn were found to bolster the mechanical properties
of different pectin-based films significantly (Lorevice et al.
2015). The electrospun fiber mats have been reported to be
a promising solution for various biomedical applications
(Balaji et al. 2015; Sill and Recum 2008). Similarly, in
another work collagen (Co) was electrospun to a degrad-
able occluder membrane by Liu et al. (2011). Co provides a
natural extracellular matrix for many body tissues like skin,
bone or ligament of connective tissue. As an endogenous
product, it is relatively non-immunogenic and does not
evoke adverse reactions (Liu et al. 2011). The procedure of
coating a biomaterial to improve its blood compatibility is
a facile approach which has shown impressive results
(Gorbet and Sefton 2004). Due to its anticoagulant prop-
erties, heparin (Hp) has been widely applied to the surfaces
of vascular implants. The Hp possesses good anti-throm-
bogenic properties making it a putative candidate as a
coating material of cardiovascular biomaterials (Chen et al.
2010; Klement et al. 2002). Hence, a novel patch com-
prising PUCnCoHp might lead to better engineered prop-
erties compared to the conventional PU patch.
In this study, PU nanofibrous membrane loaded with Cn
and Co was fabricated using electrospinning technique.
Later, this membrane was coated with Hp with an intention
to improve its blood compatibility. The final PUCnCoHp
nanocomposite membrane was characterized and its blood
compatibility properties were assessed.
Experimental
Materials
The necessary chemicals required for conducting the
research were obtained from the companies listed as fol-
lowing. The kits for activated partial thromboplastin time
(APTT) and prothrombin time (PT) were from Diagnostic
Enterprises (Parwanoo, India). They were used without any
further purification. Commercial medical grade aliphatic,
polyether-based TPU (Tecoflex EG 80A injection grade,
Lubrizol Advanced Materials, Inc., Thermedics Polymer
Products, USA) in bead form was donated by Indian
Institute of Technology, Kharagpur, India. The chitosan
powder was bought from BioBasic Inc. with a purity of
more than 90% cps. Collagen type 1 and 3 was obtained
from NeoCell Corporation. Heparin 5000 was purchased
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from Ratiopharm GmbH, Germany. Analytical grade
dimethylformamide (DMF) and glacial acetic acid (100%)
were bought from Merck AG, Germany. The sodium
tripolyphosphate (TPP) in technical grade was obtained
from Sigma Aldrich, Germany.
Chitosan nanoparticles synthesis
The series of tests performed in this study are represented
in Fig. 1. The Cn were prepared following the method
reported by Qi et al. (2004). Glacial acetic acid was diluted
with deionized water to obtain 1% v/v acetic acid. Chitosan
was dissolved using this to obtain 0.5% (w/v) solution. The
pH (HI 8424, Hanna Instruments) of the solution was found
to be 3.36 which was then raised to 4.64 with the addition
of 2.5% NaOH (1.9 ml). The triphenyl phosphate (TPP)
solution, mixed to 0.25% (w/v) with deionized water, was
added dropwise to the chitosan solution in a ratio of 1:3
under magnetic stirring to obtain chitosan nanoparticles.
Electrospinning solution preparation
Electrospinning solution was prepared using the Cn (1%)
and Co (2%) in combination with PU (4%) in the ratio of
9:0.5:0.5 (PU:Cn:Co). The pure PU patch and the com-
posite patches were spun at a flow rate of 1 ml/h with the
applied voltage of 19 kV. After completing the spinning
process, patches were dried at room temperature for
2 days.
Characterization
Spectral analysis
The Cn were analyzed using the UV–Vis spectropho-
tometer (GENESYSTM10S, Thermo Electron Scientific
Instruments, USA). The spectrum was recorded in the
range of 180–800 nm using absorbance mode. The mea-
sured absorbance gives information about bonding condi-
tions within the molecule. The scan speed was set to
medium and the measurement interval was 1.0 nm. Finally,
a plot between the wavelength and the absorbance was
obtained through the integrated software within the
equipment.
Fourier transform infrared spectroscopy
The Fourier transform infrared spectroscopy (FTIR) spec-
troscopy was performed using the Nicolet iS5 (Thermo
Electron Scientific Instruments, USA) system. FTIR spec-
tra of PU, composite patches, Cn and Co were obtained.
The spectrum was recorded over the range of
600–4000 cm-1 at 32 scans per minute with a resolution of
4 cm-1 in absorbance mode. The ATR crystal used was
zinc/selenium which was coupled with the NICOLET IS5
spectrometer. After recording, the spectra were baseline
corrected and normalized using OMNIC Specta software
(Thermo Scientific, USA) to identify the characteristic
peaks and differences.
Contact angle assay
Changes concerning the wettability of the PU composite
patch were studied using the VCA Optima (AST Products,
Inc., USA) contact angle measurement unit. The samples
were cut into rectangular shape (1 cm 9 5 cm) and placed
on the stage. The syringe, filled with distilled water, was
arranged close to the sample and a water droplet (size 1 ll)
was placed on the PU control or the composite samples.
The contact angle was measured manually with the aid of
the optical system and the corresponding VCA software.
The camera parameters were set to 70% concerning the
brightness, the contrast was set at 60% and the resolution
was at 640 9 480, to assure an evaluable image. The
experiment was conducted at room temperature.
Scanning electron microscope
Scanning electron microscope (SEM) analysis was per-
formed to evaluate the surface of the patch and to evaluate
the diameter of the nanofibers. Therefore, a small piece of
the respective membrane was cut and pasted on a coin by
using double-sided tape. The sample was then adjusted on
the stage and sputter coated with gold to obtain an elec-
trically conductive surface using the BioRad Polaron
Division. To obtain the surface images, the Hitachi
Table Top Microscope (TM3000) coupled with EDS
analysis system was used. The samples were imaged at a
magnification of 60009 and 70009. The average diameter
and standard deviation (SD) of the PU and the composite
fibers were determined using GIMP image analysis system
(n = 10).
Blood compatibility assessment
All the experimental procedures incorporated in the treat-
ment of blood were approved by the Faculty of Biosciences
and Medical Engineering, Universiti Teknologi Malaysia
with ref no: UTM.J.45.01/25.10/3Jld.2(3). Eight ml blood
was taken from a voluntary donor and stored in coagulation
blood collective tubes. The tubes were stored at 4.5 C in
the refrigerator before any further use. For the coagulation
assays, 4 ml whole blood was centrifuged at 3000 rpm for
10 min. The supernatant platelet-poor plasma (PPP) was
used for further experimentation. The patches were placed
in a 96-well plate for conducting the APTT and PT.
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Fig. 1 Schematic representation of this study
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Activated partial thromboplastin time
Activated partial thromboplastin time is a highly reliable
basic blood compatibility test, suitable for detecting the
capability of blood coagulation through the intrinsic
coagulation pathway. It helps us to understand how the
contact of the blood with biomaterials affects the activation
of the coagulation pathway. The samples were thoroughly
washed with deionized water, incubated in PBS for 30 min
at 37 C. The substrates were pre-incubated with 50 lL
PPP at 37 C and then activated by incubating with 50 lL
rabbit brain cephalin (ratio 1:1) for 2 min. For initiating
clot formation, 50 lL calcium chloride was added to the
mixture. The time for initiation of clot formation was
measured immediately using a stopwatch (Jaganathan et al.
2017; Manikandan et al. 2017). A steel needle of diameter
23 mm was used to investigate the formation of clot.
Prothrombin time
Similarly, the time taken for the formation of the clot
through extrinsic pathway was estimated through pro-
thrombin assay. The PT is expressed as a ratio called
international normalized ratio (INR) in which the time for
the sample clot is relative to the control sample. The INR
normally ranges between 0.8 and 1.4 (Eyre and Gamlin
2010). In this assay, the samples were rinsed in deionized
water and incubated in PBS at 37 C for 30 min. Rabbit
brain NaCl–thromboplastin (0.9%) containing Ca2? was
added to the substrate, pre-incubated in PPP (50 lL). Then,
the mixture was slowly stirred using a steel needle
(ø23 mm) and the time taken for the onset of fibrin for-
mation was determined using a stopwatch (Jaganathan
et al. 2017; Manikandan et al. 2017).
Hemolysis ratio
The hemolysis ratio analyzes the impact on red blood cells
(RBC) when they interact, e.g., biomaterials evokes any
lysis of the RBC. The samples were cut into squares
(10 mm 9 10 mm) before placing into 0.8 ml citrated
whole blood diluted in 1 ml of saline. Subsequently, a
positive and a negative control were prepared. The positive
control consisted of 0.8 ml of blood with 1 ml distilled
water; whereas the negative control was physiological
saline. The incubation time was 60 min at a temperature of
37 C. The mixtures were centrifuged at 3000 rpm for
10 min and the hemolytic percentage was determined using
photometric analysis of the supernatant. Therefore, 0.8 ml
of the supernatant was placed into a 1-ml cuvette for
measuring the absorbance. The absorbance of the super-
natant was measured at 542 nm to quantify the amount of
hemoglobin released in order to estimate the eventual
degree of damage to the RBC (Amarnath et al. 2006;
Wright 2006). The hemolysis ratio was calculated using the
below mentioned formula. TS is the absorbance of the test
sample, whereas NC and PC are the absorbance’s of the
negative and positive control, respectively:
H ¼ TS  NC
PC  NC : ð1Þ
Fluid uptake ability
Water uptake ability of the PU and composite patches over
a certain time span was measured as follows. Samples were
cut into 10 mm 9 10 mm and placed in phosphate buf-
fered saline at a pH adjusted to 7.4. The temperature was
kept stable at room temperature. The patches were
immersed in water for the time span of 6, 12 and 24 h.
After immersion, the patches were then placed on to a fresh
absorbing paper for 30 s and their weight was measured.
The fluid uptake ability (FUA, %) of the composite patch
and the control sample was calculated as a percentage of
water loss per unit weight:
FUA ð%Þ ¼ Ww W0
Ww
 100;
where Ww is the wet weight of the nanofiber and W0 is the
dry weight of the nanofiber (Zhou and Gong 2008).
Statistical analysis
All quantitative experiments were performed three times
(n = 3) for each sample. The statistical analysis was car-
ried out using one-way ANOVA method and all results are
expressed as mean ± standard deviation.
Results and discussion
Characterization
Synthesis of chitosan nanoparticle: UV–Vis analysis
The peak or the highest absorption (absorbance = 1) was
found at a wavelength of 289 nm which is depicted in
Fig. 2. This peak confirms the formation of nanoparticles
as reported recently by Liu and Gao (2009). The authors
found a similar peak in this wavelength in UV–Vis and
ascribed it to the color change from transparent to opal
during the addition of the TPP to the chitosan solution.
Likewise, researchers reported that distilled water is com-
monly used as a chemical-blowing agent. It evokes an
exothermic reaction resulting in the formation of highly
viscous product when it gets in contact with PU (Thirumal
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et al. 2008). Hence, a minimal water level in the Cn will
make the final composite solution spinnable.
Fourier transform infrared spectroscopy
The recorded FTIR result of Co and Cn is given in Fig. 3.
Likewise, the recorded FTIR spectrum, which compares
the PU control sample with the PU composite patch with
and without Hp coating is displayed in Figs. 4 and 5,
respectively. The FTIR spectrum of electrospun PU nano-
fibers displayed similar characteristic absorption bands
compared to the composite patches with some differences.
A variation in the intensities were noted for both control
and coated samples at wave numbers 754, 794, 838, 1025,
1088, 1270, 1285, 1335, 1425, 1440, 1459, 1492, 1719 and
2893 cm-1. The FTIR spectroscopy of PU has character-
istic absorption bands at &3290, &1700, &1600, &1525,
&1220 cm-1, which are associated with different groups
in the PU molecule m (–N–H), m(–C=0), m(–C–N), m(–C=C),
m(–C–O–C), respectively (Yang et al. 2011). These peaks
are all represented in the PU control spectrum. The com-
posite shows some additional peaks and changes with
regard to the absorbance. Between 600 and 800 cm-1 the
absorbance of the patch is less than the one of the control
patch and similar observations were reflected at around
1100, 1200 and 1650 cm-1. In contrast, at the wavelength
Fig. 2 Spectral analysis of the Cn using UV–Vis with a maximum absorption at 289 nm
Fig. 3 Fourier transform infrared spectroscopy of the patch ingredients Co and Cn
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of &3320 cm-1 the composite patch shows a higher
absorption. The Co was used as reference sample and
showed peaks at 1640, 1540 and 1280 cm-1, which rep-
resent the amide I, II and III bands of Co (Wong and Badri
2012). The Hp-coated patch shows the same differences as
the uncoated composite compared to the reference sample,
except a peak at 2300 cm-1.
Besides that, when the composite PUCnCo was com-
pared with the PU, it did not show any major alteration in
the functional groups due to the small amount of active
ingredients in the patch. The composite patch shows a
characteristic absorption band for Cn at the wavenumber
1095 cm-1 m(C–=). The changes at the wave number 1650
is due to the functional group of (C=0) of the Cn and the
lower absorption at 1100 cm-1 is caused by the m(C–O–C),
respectively (Rinaudo 2006). The composite shows some
shifts concerning the absorbance, which is attributed to the
Cn for the wavenumbers around 600–700 cm-1. Due to the
addition of Co, the absorption shifts at 1600 cm-1, the
peaks at 1540, 1456 and 1363 cm-1 also indicate the
presence of Co and represent its triple helix structure
(Pedicini and Farris 2003). The peak in the Hp-coated
sample at 2300 cm-1 peak refers to the S–H stretch in the
Hp which was absent in the other samples. Likewise, the
Fig. 4 FTIR of the PU patch in comparison with the PU composite patch. The changes in the functional groups are highlighted
Fig. 5 Fourier transform infrared spectroscopy of the PU composite in comparison with the composite coated with Hp
3 Biotech (2017) 7:174 Page 7 of 12 174
123
changes at 1256 cm-1 as well as the lower absorption at
1078 cm-1 are characteristic for the –OSO3(S=O) indi-
cating the presence of Hp (Chen et al. 2016). Lastly, the
peak at 3320 cm-1 indicates a change concerning the
hydrophilic properties of the patch due to Co and Cn where
both show a peak in their spectrum at the mentioned
wavenumbers.
Contact angle
The contact angle was expressed as mean value of the three
measurements and the standard deviation as displayed in
Fig. 6. The mean contact angle calculated for the PU ref-
erence was 84:23 ± 1.06, the composite without coating
had a mean contact angle of 87:62 ± 3.73 and the hep-
arin-coated patch showed a contact angle of
90:42 ± 1.41. The statistical analysis did not show a
significant (p\ 0.05) difference between the control and
the composite patch. Surfaces with suitable hydrophilic
properties show a better cell adherence and support an
effective spread compared to hydrophobic surfaces. The
wettability, or contact angle assay, is used to evaluate the
hydrophilicity of the sample surface (Wang et al. 2015). To
prove the wettability of the developed patch, the contact
angle is used as a common tool in several studies. PU has
not always shown the best biocompatibility in application,
but there are several methods to improve the wettability,
e.g., adding, coating or blending the PU with bioactive
agents like chitosan or collagen (Maria et al. 2012). The
mixture of biopolymers and synthetic ones can result in a
synergistic effect of improved biocompatibility with easy
processability and improved mechanical characteristics
(Barikani et al. 2010). In this study, the contact angle of the
PU and the developed patches revealed no significant dis-
parity, even though slightly higher values were determined
for the composite and even more after the coating with Hp.
This might be caused by the hydrophobic character of the
Cn (Liu et al. 2011; Mit-uppatham et al. 2004). In con-
clusion, a significant change could not be demonstrated in
the wettability of the developed patch.
Scanning electron microscope
The surface characteristics of an electrospun patch used for
ASD closure are essential with respect to the biocompati-
bility and cell adherence. The SEM allows an evaluation of
the surface’s topographical characteristics, e.g., roughness
or presence of pits as well as the determination of the
nanofiber diameter. Respective images are shown in Fig. 7.
The diameter of the nanofiber of the PU reference was
found to be 445.71 ± 34.89 nm, the PUCnCo fibers were
slightly smaller with a mean diameter of 275 ± 61.65 nm,
as displayed in Fig. 8. An even structure and uniform patch
is another important factor which can have an impact on
the biocompatibility of the patch, therefore the nanofiber
diameter was evaluated. In accordance with a study of Kim
et al. the PU nanofiber diameter ranged from 0.4 to 2.1 lm
(Kim et al. 2009). Liu et al. developed a biodegradable
occlusion device using electrospinning with PLGA and Co.
They have shown that the diameter of the nanofibers ran-
ged between 130 and 520 nm (Liu et al. 2011). The
developed patches as well as the PU control patch are in the
similar range reported in the above studies. The diameter of
the composite nanofiber patch decreased compared to the
PU reference. This can be due to the addition of Co which
decreases the viscosity of the solution. The lower viscosity
is caused by a reduction of the viscoelastic force and the
Coulombic stretching. This fact leads to the observed
reduction in the nanofiber diameter (Liu and Gao 2009; Li
et al. 2008). The reduced diameter of the nanofibers leads
into a smaller nanofiber matrix which may be linked to
better cell proliferation and adhesion. Recently, Chen et al.
Fig. 6 Mean contact angle
values of control, composite and
coated samples with standard
deviation
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(2007) demonstrated the enhanced adhesion of fibroblasts
on reduced nanofiber matrices. Similar findings were
reported with neural stem cells (Christopherson et al.
2009). These observations which are in consensus with the
result of this study bolster the feasibility of the fabricated
electrospun nanofiber to be used for cardiac patch appli-
cation. No bead formation was found for the PU control. In
the PUCnCo slight bead formation could be determined,
probably triggered by the diminution of the solution vis-
cosity (Kim et al. 2009; Li et al. 2008). Regarding the
structural uniformity, the distribution of the control fiber
across the sheet is uniform, isotropic and homogeneous.
The composite showed comparable good results as control.
Fluid uptake percentage
The fluid uptake was evaluated on the basis of three
measuring points. The graphs depict that the pure PU patch
shows a higher swelling ability than the composite patch.
The mean fluid uptake of the PU was more than double the
PUCnCo/PUCnCoHp uptake. The mean value for the fluid
uptake for all three samples over the measurement points
with standard deviation and significance is indicated in
Fig. 9. The difference between the control and the samples
fluid uptake indicates that the PU absorbs the fluid within a
Fig. 7 a, b Electrospun PU patch SEM images at magnification of 96000 and 97000, respectively. c, d Electrospun PUChCo patch SEM
images at magnification of 96000 and 97000, respectively
Fig. 8 Fiber diameters of the electrospun polymer sheets, displayed
with their mean value as 445.7 for the PU patch and 275.0 for the
composite. The standard deviation is shown, pointing out the
uniformity of the patches
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significantly higher range (p\ 0.05) than the composite
for all three measuring points. For the two composites no
significant difference could be found. Over the time span of
24 h, the fluid uptake was increased linearly. The linear
gradient for PU is 0.94, for the PUCnCo is 0.69 and for the
Hp-coated sample is 0.55. The fluid uptake test indicated
that the PU can absorb fluid significantly compared to the
composites (p\ 0.05). The fluid uptake rate is an indicator
for the biocompatibility of a patch. In this case, the FUA %
significance might be caused by the hydrophobic character
of the Cn. Regarding the difference between the uncoated
and the coated patch, no significance is displayed. Even
though the fluid uptake is an index for the biocompatibility
in this application, a lower FUA % is sensible. Since, it is
directly implanted in the blood circuit a high uptake might
cause changes in the mechanical properties of the patch and
might lead into its destruction.
Blood compatibility assessment
Activated partial thromboplastin time
Activated partial thromboplastin time assay was performed
for the two composite patches and the control PU. The
mean values are illustrated in Fig. 10a. The control PU
sample had a mean clotting time of 72.92 ± 15.84 s. The
PUCnCoHp showed a significant (p\ 0.05) delay of clot
formation while the uncoated composite patch showed no
significant change. It even demonstrated a lower mean
value compared to the control of 70.77 ± 4.06 s. The
coated sample exhibited an increased clot formation time
of 103.33 ± 4.75 s. APTT is utilized for studying the
propensity of blood to coagulate via intrinsic pathway and
to determine the effect of biomaterials on delaying the
blood clotting process. This test is the most frequently used
method to monitor anticoagulant response in clinical set-
tings (Fong et al. 1999; Elahi et al. 2014). Hence, the
increase of the APTT for the Hp-coated sample indicates a
delay of the activation of the intrinsic pathway.
Prothrombin time
The PT is measured to analyze the impact the developed
patches in the clot formation through the extrinsic pathway.
As for the APTT, the experiment was carried out three
times for each sample (n = 3). The PT is illustrated in
Fig. 10b. Similar to the APTT only the coated sample
showed a significant difference (p\ 0.05) in comparison
with the control PU. It was found to be 35.57 ± 2.74 s,
compared to the control with a mean of 25.73 ± 2.32 s.
The uncoated PUCnCo presented a mean value of
29.4 ± 0.59 s.
In contrast to the APTT, the PT measures the integrity of
the extrinsic pathway. In this study, the PT was signifi-
cantly increased for the Hp-coated patch and only slightly
elevated for the PUChCo patch without any significance.
This result is in corroboration with the results obtained in a
work done by Yang et al. (2011), where the Hp coating
prolongs the PT due to its antithrombogenicity. The com-
posite PuChCoHp showed the highest PT, which leads to
the assumption of the best blood compatibility among the
different patches fabricated in this study.
Hemolysis ratio
The mean absorbance for the control was determined as
0.159. For the two composite patches it was 0.105 for the
PUChCo and 0.094 for the PUCnCoHp, shown in Fig. 10c.
The HR was then calculated with formula (1). For the
control the mean was found as 3.64%, for the PUCnCo was
2.39% and PUCnCoHp was 2.12%. The hemolysis ratio
indicates the compatibility of a biomaterial with RBC.
When RBCs gets in contact with artificial material like the
PU patch, the RBC membrane is exposed to a massive
dynamic stress. To evaluate this osmotic stress on the
RBCs, the hemolysis assay is performed (Vellayappan
et al. 2016). According to the ASTM F 756-00 (2000)
standard materials are classified into three categories
according to their hemolytic ratio. If the percentage is
above 5% materials are classified as hemolytic, if between
5 and 2% they are considered as moderately hemolytic and
below 2% it is classified as non-hemolytic material. In this
study, the hemolysis ratio was found to be 3.00, 2.61 and
Fig. 9 Mean value for the fluid uptake for all three samples over the
measurement points with standard deviation and significance
indicated
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2.33%, respectively, for the pristine PU, PUChCo and
PUChCoHp patches. Since the ratio is beneath the men-
tioned mark of 5%, all the patches can be considered as
compatible with RBCs. However, the PUChCoHp patches
demonstrate the best result compared to other samples.
Hence, the overall result of this study suggests that the
novel PUChCoHp patches can be considered as a potential
candidate for cardiac patch application.
Conclusion
A biodegradable patch for the occlusion of ASD was
developed and tested. Developed composite patch dis-
played reduced fiber diameter compared to the pristine PU.
FTIR analysis indicated the presence of functional groups
unique to chitosan, collagen and heparin added in the
composite. Contact angle and fluid uptake were in agree-
ment to the desired properties of ASD patch. Further,
coating of heparin on the composite patch delayed the
APTT and PT significantly. Also, the hemolysis ratio was
reduced expressing the feasibility of the developed patch
for ASD occluder. Even though the results are promising,
further in vivo tests need to be conducted to assure the
abilities of the developed ASD patch before promoting it to
clinical trials.
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